Published in J Biol Chem on June 20, 1997
Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev (1998) 4.49
Saccharomyces cerevisiae transcription elongation mutants are defective in PUR5 induction in response to nucleotide depletion. Mol Cell Biol (2000) 2.16
Architecture of the RNA polymerase II preinitiation complex and mechanism of ATP-dependent promoter opening. Nat Struct Mol Biol (2012) 1.48
Altered nucleosome occupancy and histone H3K4 methylation in response to 'transcriptional stress'. EMBO J (2005) 1.35
Mutations in RNA polymerase II and elongation factor SII severely reduce mRNA levels in Saccharomyces cerevisiae. Mol Cell Biol (1998) 1.32
Genetic analysis of the large subunit of yeast transcription factor IIE reveals two regions with distinct functions. Mol Cell Biol (1997) 1.23
TFE, an archaeal transcription factor in Methanobacterium thermoautotrophicum related to eucaryal transcription factor TFIIEalpha. J Bacteriol (2001) 1.08
An interplay between TATA box-binding protein and transcription factors IIE and IIA modulates DNA binding and transcription. Proc Natl Acad Sci U S A (1998) 1.02
Inactivated RNA polymerase II open complexes can be reactivated with TFIIE. J Biol Chem (2011) 0.84
Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. Isolation and characterization of the regulatory gene GAL4. Mol Gen Genet (1983) 2.66
GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1988) 2.41
TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A (1996) 2.31
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
Primary structure of the Saccharomyces cerevisiae GAL7 gene. Yeast (1985) 2.02
Nucleotide sequence of the yeast regulatory gene GAL80. Nucleic Acids Res (1984) 1.91
The pathogenesis of experimental membranous glomerulonephritis induced with homologous nephritogenic tubular antigen. J Exp Med (1976) 1.87
Nucleotide sequence of the transcriptional initiation region of the yeast GAL7 gene. Nucleic Acids Res (1983) 1.77
Signal sequence for generation of mRNA 3' end in the Saccharomyces cerevisiae GAL7 gene. EMBO J (1990) 1.76
Yeast Gal11 protein mediates the transcriptional activation signal of two different transacting factors, Gal4 and general regulatory factor I/repressor/activator site binding protein 1/translation upstream factor. Proc Natl Acad Sci U S A (1990) 1.74
Duplicate upstream activating sequences in the promoter region of the Saccharomyces cerevisiae GAL7 gene. Mol Cell Biol (1986) 1.66
Galactose-dependent reversible interaction of Gal3p with Gal80p in the induction pathway of Gal4p-activated genes of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 1.65
Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. II. The isolation and dosage effect of the regulatory gene GAL80. Mol Gen Genet (1984) 1.62
Analysis of the galactose signal transduction pathway in Saccharomyces cerevisiae: interaction between Gal3p and Gal80p. Mol Cell Biol (1996) 1.51
Controlled transcription of the yeast regulatory gene GAL80. Gene (1985) 1.40
Acute effects of fracture on bone markers and vitamin K. Clin Chem (1998) 1.38
Laboratory model of membranous glomerulonephritis in rats induced by pronase-digested homologous renal tubular epithelial antigen. Lab Invest (1975) 1.34
Mechanism of host-controlled restriction of bacteriophage lambda by R factors in Escherichia coli K12. Virology (1968) 1.32
C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal. Jpn J Cancer Res (1999) 1.31
Specific inactivation of infectious lambda DNA by sonicates of restrictive bacteria with R factors. Biochem Biophys Res Commun (1966) 1.27
Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol (1999) 1.23
The enzymes of the galactose cluster in Saccharomyces cerevisiae. II. Purification and characterization of uridine diphosphoglucose 4-epimerase. J Biol Chem (1980) 1.20
Functional domains of a negative regulatory protein, GAL80, of Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.19
Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol (2001) 1.13
Regional replication of the bacterial chromosome induced by derepression of prophage lambda. J Mol Biol (1970) 1.09
The enzymes of the galactose cluster in Saccharomyces cerevisiae. Purification and characterization of galactose-1-phosphate uridylyltransferase. J Biol Chem (1979) 1.09
The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor. Biochem Biophys Res Commun (2000) 1.08
Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene (2009) 1.07
Purification and characterization of the yeast negative regulatory protein GAL80. J Biol Chem (1991) 1.06
Purification of yeast histones competent for nucleosome assembly in vitro. Yeast (1994) 1.06
Evaluation of isolated fractures of the greater trochanter with magnetic resonance imaging. Arch Orthop Trauma Surg (2000) 1.05
Urinary pyridinoline and deoxypyridinoline in prostate carcinoma patients with bone metastasis. Br J Cancer (1994) 1.05
Fluorophores from aging human articular cartilage. J Biochem (1991) 1.04
Yeast GAL11 protein is a distinctive type transcription factor that enhances basal transcription in vitro. Proc Natl Acad Sci U S A (1993) 1.03
Adaptation of Comamonas testosteroni TA441 to utilize phenol: organization and regulation of the genes involved in phenol degradation. Microbiology (1998) 1.02
Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford) (1999) 0.99
Arrangement and regulation of the genes for meta-pathway enzymes required for degradation of phenol in Comamonas testosteroni TA441. Microbiology (2000) 0.99
Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum (1994) 0.98
An evolutionarily conserved G-protein coupled receptor family, SREB, expressed in the central nervous system. Biochem Biophys Res Commun (2000) 0.98
Regional replication of the bacterial chromosome induced by derepression of prophage lambda. IV. Escape synthesis of gal operon in phage 82. Mol Gen Genet (1978) 0.97
Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis. Calcif Tissue Int (2000) 0.97
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J (2005) 0.96
Functional connections between mediator components and general transcription factors of Saccharomyces cerevisiae. J Biol Chem (2000) 0.96
Genetic organization and characteristics of the 3-(3-hydroxyphenyl)propionic acid degradation pathway of Comamonas testosteroni TA441. Microbiology (1999) 0.95
Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system. Mol Pharmacol (1989) 0.94
Molecular cloning and characterization of another leukotriene B4 receptor. J Biol Chem (2000) 0.94
Autogenous regulation of the Saccharomyces cerevisiae regulatory gene GAL80. Mol Gen Genet (1987) 0.92
Two alternative pathways of transcription initiation in the yeast negative regulatory gene GAL80. Mol Cell Biol (1994) 0.92
Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes (2000) 0.91
Experimental membranous glomerulonephritis in rats: correlation of ultrastructural changes with the serum level of autologous antibody against tubular antigen. Lab Invest (1978) 0.88
Adaptation of Comamonas testosteroni TA441 to utilization of phenol by spontaneous mutation of the gene for a trans-acting factor. Mol Microbiol (1999) 0.88
Possible mechanisms of diethyldithiocarbamate-induced gastro-duodenal mucosal damage in rats. Scand J Gastroenterol Suppl (1989) 0.87
The yeast GAL11 protein binds to the transcription factor IIE through GAL11 regions essential for its in vivo function. Proc Natl Acad Sci U S A (1996) 0.87
Chromosome mobilization in rec-merodiploids of Escherichia coli K12 following infection with bacteriophage lambda. Virology (1969) 0.87
Regional replication of the bacterial chromosome induced by derepression of prophage lambda. II. Direction and origin. Mol Gen Genet (1976) 0.86
Role in nitric oxide in Kupffer cell-mediated hepatoma cell cytotoxicity in vitro and ex vivo. Hepatology (1996) 0.86
Yeast Gal11 and transcription factor IIE function through a common pathway in transcriptional regulation. J Biol Chem (1997) 0.86
Quantitation of the crosslinks, pyridinoline, deoxypyridinoline and pentosidine, in human aorta with dystrophic calcification. Atherosclerosis (1995) 0.86
Uridine diphosphate glucose-4-epimerase and galactose-1-phosphate uridylyltransferase from Saccharomyces cerevisiae. Methods Enzymol (1982) 0.85
Intratumoral ethanol injection for malignant tracheobronchial lesions: a new bronchofiberscopic procedure. Endoscopy (1986) 0.85
Treatment of cryptococcal meningitis with pulmonary granuloma. J Neurol (1984) 0.85
Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism. Eur J Clin Pharmacol (2004) 0.84
[Effect of histamine on immunoglobulin production of human B cells stimulated by Staphylococcus aureus Cowan I and interleukin 2]. Arerugi (1987) 0.84
Activator-specific requirement for the general transcription factor IIE in yeast. Biochem Biophys Res Commun (1999) 0.84
Isolation and characterization of SGE1: a yeast gene that partially suppresses the gal11 mutation in multiple copies. Genetics (1993) 0.84
A novel domain of the yeast heat shock factor that regulates its activation function. Biochem Biophys Res Commun (2001) 0.83
[Estimation of probiotics by infection model of infant rabbit with enterohemorrhagic Escherichia coli O157:H7]. Kansenshogaku Zasshi (1998) 0.83
Sequence analysis of elastin cDNA from chick aorta and tissue-specific transcription of the elastin gene in developing chick embryo. Arch Biochem Biophys (1987) 0.82
A flower-shaped cannula for three-incision laparoscopic cholecystectomy. Surg Endosc (1998) 0.82
Humoral immune function in severe, active rheumatoid arthritis. Clin Immunol Immunopathol (1987) 0.82
[Nephrotoxicity of cefpirome sulfate in rabbits--single and multiple intravenous administration]. J Toxicol Sci (1990) 0.82
Clinical outcomes of laparoscopic adhesiolysis for mechanical small bowel obstruction. Asian J Endosc Surg (2011) 0.81
Bone turnover and cortical bone mineral density in the distal radius in patients with hyperthyroidism being treated with antithyroid drugs for various periods of time. Clin Endocrinol (Oxf) (1999) 0.81
The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures. Osteoporos Int (1999) 0.80
[A clinical study on patients detected Pasteurella multocida from sputum]. Kansenshogaku Zasshi (2001) 0.80
Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane. J Cancer Res Clin Oncol (2002) 0.80
The Maillard protein cross-link pentosidine in urine from diabetic patients. Diabetologia (1993) 0.80
Th1 and Th2 cytokines differentially regulate the transformation of Kupffer cells into multinucleated giant cells but similarly enhance the Kupffer cell-induced hepatic stellate cell proliferation. Hepatol Res (2001) 0.80
Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone (1998) 0.80
The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function. Diabetes Obes Metab (2011) 0.79
Mechanism of action of parathyroid hormone-induced proteoglycan synthesis in the growth plate chondrocyte. J Orthop Res (1990) 0.79
A novel mutation that affects utilization of galactose in Saccharomyces cerevisiae. Curr Genet (1980) 0.79
Urinary excretion of type I collagen degradation products in healthy women and osteoporotic patients with vertebral and hip fractures. Calcif Tissue Int (1998) 0.79
Annexin XI may be involved in Ca2+ - or GTP-gammaS-induced insulin secretion in the pancreatic beta-cell. FEBS Lett (2000) 0.79
Strain-specific lethal effect of the adenovirus E1a protein on Saccharomyces cerevisiae. Biochem Biophys Res Commun (1990) 0.79
GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1992) 0.79
The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Calcif Tissue Int (1994) 0.78
Spermatocytic seminoma with neuroectodermal differentiation and sertoli cell tumor in a dog. Vet Pathol (2010) 0.78
Application of in situ hybridization technique for quantitative assessment of ongoing symptomatic Epstein-Barr virus infection after living related liver transplantation. Clin Transplant (1998) 0.78
Clinical significance of specific IgE antibody against streptokinase-streptodornase in renal diseases of childhood. Int Arch Allergy Appl Immunol (1977) 0.78
Epstein-Barr virus genome-positive tubulointerstitial nephritis associated with immune complex-mediated glomerulonephritis in chronic active EB virus infection. Virchows Arch (1998) 0.78
Steroidal glycosides from the bulbs of Allium jesdianum. J Nat Prod (1999) 0.78
Expression of the human adenovirus E1a product in yeast. Gene (1987) 0.78
Characterization of secretory and morphologic properties of primary cultured endocrine cells from porcine pancreata. Pancreas (2001) 0.77
In vitro and in vivo antitumor effects of murine monoclonal antibody NCC-ST-421 reacting with dimeric Le(a) (Le(a)/Le(a)) epitope. Cancer Res (1991) 0.77
Core promoter elements are essential as selective determinants for function of the yeast transcription factor GAL11. FEBS Lett (1996) 0.77